ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
ClearPoint Neuro, Inc. (CLPT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $10.81 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-03-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $10.81M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $21.17M.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $8.89M.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $8.90M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2025-12-31 | $10.81M 10-K · filed 2026-03-17 |
| 2025-09-30 | $21.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $8.89M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $8.90M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $13.22M 10-K · filed 2025-02-26 |
| 2024-09-30 | $8.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.18M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.53M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.55M 10-K · filed 2024-03-12 |
| 2023-09-30 | $1.87M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.10M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.33M 10-K · filed 2023-03-01 |
| 2021-12-31 | $8.35M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |